http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019500382-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 |
| filingDate | 2016-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019500382-A |
| titleOfInvention | Pharmaceutical composition for treating cancer and inhibiting metastasis comprising a sulfonamide compound as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for treating cancer and inhibiting metastasis comprising a sulfonamide compound as an active ingredient. More specifically, the sulfonamide antibiotic Sulfisoxazole or sulfadoxine The new use of (sulfadoxine) relates to cancer prevention, treatment, and metastasis inhibiting effects. The sulfonamide compound of the present invention has an excellent effect of inhibiting the growth, invasion, and migration of cancer cells in addition to the conventionally known antibacterial effect, and the optimal dose and side effects have already been established. Since it is a drug, it is very likely that it can be used clinically in a composition for cancer treatment and metastasis suppression. |
| priorityDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.